Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02495389 · ClinicalTrials.gov registry record · Phase 4
Mirabegron and Urinary Urgency Incontinence
A Phase 4 study, sponsored by Loyola University.
- Completed
- Registry status
- Phase 4
- Development phase
- 84
- Enrollment target
NCT02495389 is a Phase 4 study that has completed, run by Loyola University. The registered enrollment target is 84 participants.
The verdict
NCT02495389, a Phase 4 study, has completed, sponsored by Loyola University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 84 participants
- Enrollment target
Study Summary
This study is for women diagnosed with urinary urgency incontinence (UUI) or overactive bladder (OAB). Some patients continue to have symptoms even while taking medication for OAB. The purpose of this study is to estimate the number of women who respond to a medication called mirabegron and estimate change in symptom severity over 12 weeks of therapy. A secondary goal is to correlate the female urinary microbiome (FUM) with response to treatment and change in symptom severity over 12 weeks of therapy.
Interventions
- DRUG Mirabegron
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2015-01-28 |
| Est. Completion | 2019-01-29 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02495389
The ClinicalTrials.gov registry entry for NCT02495389 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loyola University, which has 92 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mirabegron is the first listed.
NCT02495389 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02495389 about?
NCT02495389 is a clinical study titled "Mirabegron and Urinary Urgency Incontinence". This study is for women diagnosed with urinary urgency incontinence (UUI) or overactive bladder (OAB). Some patients continue to have symptoms even while taking medication for OAB. The purpose of this study is to estimate the number of women who respond to a medication called mirabegron and estimate...
What is the current status of trial NCT02495389?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 84 participants. The study started on 2015-01-28. Estimated completion is 2019-01-29.
What interventions are being tested in trial NCT02495389?
The interventions under investigation include: Mirabegron (DRUG).
Who is sponsoring clinical trial NCT02495389?
This trial is sponsored by Loyola University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.